Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy L Seybert

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
The Annals of Pharmacotherapy|August 18, 2005
Outcomes and costs of abciximab versus eptifibatide for percutaneous coronary interventionJames C Coons, Amy L Seybert, Melissa I Saul, et al.
The Annals of Pharmacotherapy|March 6, 2009
Coronary vasospasm and atrial fibrillation associated with ondansetron therapyPamela L Havrilla, Sandra L Kane-Gill, Margaret M Verrico, et al.
Journal of Critical Care|October 27, 2017
Intensive care unit drug costs in the context of total hospital drug expenditures with suggestions for targeted cost containment effortsShoroq M Altawalbeh, Melissa I Saul, Amy L Seybert, et al.
Journal of the American Pharmacists Association : Japha|April 8, 2016
Prescription opioid use: Patient characteristics and misuse in community pharmacyGerald Cochran, Jennifer L Bacci, Thomas Ylioja, et al.
The Annals of Pharmacotherapy|October 21, 2010
Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankingsPamela L Smithburger, Sandra L Kane-Gill, Neal J Benedict, et al.
Journal of Patient Safety|March 21, 2014
Prospective Assessment of Inpatient Boxed Warning Prescriber AdherenceMegan A Kloet, Brian R Lohr, Pamela L Smithburger, et al.
Journal of the American College of Clinical Pharmacy : JACCP|April 25, 2022
Interinstitutional simulation of patients with COVID-19 during a remote acute-care advanced pharmacy practice experienceMichael W Perry, Lawrence R Kobulinsky, Amy L Seybert, et al.
Pharmacoepidemiology and Drug Safety|February 27, 2013
Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summariesAnanth M Anthes, Lisa M Harinstein, Pamela L Smithburger, et al.
Pharmacy (Basel, Switzerland)|January 24, 2019
Effects of Cross-Training on Medical Teams' Teamwork and Collaboration: Use of SimulationAshley R Hedges, Heather J Johnson, Lawrence R Kobulinsky, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 6, 2021
Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) DatabaseLindsay N Moreland-Head, James C Coons, Amy L Seybert, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
The Annals of Pharmacotherapy|August 18, 2005
Outcomes and costs of abciximab versus eptifibatide for percutaneous coronary interventionJames C Coons, Amy L Seybert, Melissa I Saul, et al.
The Annals of Pharmacotherapy|March 6, 2009
Coronary vasospasm and atrial fibrillation associated with ondansetron therapyPamela L Havrilla, Sandra L Kane-Gill, Margaret M Verrico, et al.
Journal of Critical Care|October 27, 2017
Intensive care unit drug costs in the context of total hospital drug expenditures with suggestions for targeted cost containment effortsShoroq M Altawalbeh, Melissa I Saul, Amy L Seybert, et al.
Journal of the American Pharmacists Association : Japha|April 8, 2016
Prescription opioid use: Patient characteristics and misuse in community pharmacyGerald Cochran, Jennifer L Bacci, Thomas Ylioja, et al.
The Annals of Pharmacotherapy|October 21, 2010
Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankingsPamela L Smithburger, Sandra L Kane-Gill, Neal J Benedict, et al.
Journal of Patient Safety|March 21, 2014
Prospective Assessment of Inpatient Boxed Warning Prescriber AdherenceMegan A Kloet, Brian R Lohr, Pamela L Smithburger, et al.
Journal of the American College of Clinical Pharmacy : JACCP|April 25, 2022
Interinstitutional simulation of patients with COVID-19 during a remote acute-care advanced pharmacy practice experienceMichael W Perry, Lawrence R Kobulinsky, Amy L Seybert, et al.
Pharmacoepidemiology and Drug Safety|February 27, 2013
Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summariesAnanth M Anthes, Lisa M Harinstein, Pamela L Smithburger, et al.
Pharmacy (Basel, Switzerland)|January 24, 2019
Effects of Cross-Training on Medical Teams' Teamwork and Collaboration: Use of SimulationAshley R Hedges, Heather J Johnson, Lawrence R Kobulinsky, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 6, 2021
Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) DatabaseLindsay N Moreland-Head, James C Coons, Amy L Seybert, et al.
Pageof 6